FAQ

benztropine mesylate 0.5 MG Oral Tablet

Known as: BENZTROPINE MESYLATE 0.5MG TAB [VA Product], BENZTROPINE MESYLATE 0.5 mg ORAL TABLET [Benztropine Mesylate], BENZTROPINE MESYLATE 0.5MG TAB UD 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2018
01220022018

Related topics

Related topics

30 relations
Abnormalities, Drug-InducedBladder neck obstructionCorn OilCroscarmellose Sodium
(More)

Broader (2)

BenztropineParasympatholytics

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
benztropine mesylate 0.5 MG Oral Tablet
Parkinson Disease
Drug Allergy
Silicon Dioxide
Peptic Ulcer
Intestinal Obstruction

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Induction of Cannabinoid- and N-Methyl-d-Aspartate Receptor-Mediated Long-Term Depression in the Nucleus Accumbens and Dorsolateral Striatum Is Region and Age Dependent
BACKGROUND The adolescent brain is sensitive to experience-dependent plasticity and might be more vulnerable than the adult brain… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex.
Preclinical and clinical studies show that cannabis modulates mood and possesses antidepressant-like properties, mediated by the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
TASK-3 knockout mice exhibit exaggerated nocturnal activity, impairments in cognitive functions, and reduced sensitivity to inhalation anesthetics.
The TASK-3 channel is an acid-sensitive two-pore-domain K+ channel, widely expressed in the brain and probably involved in… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
The in vivo contributions of TASK-1-containing channels to the actions of inhalation anesthetics, the alpha(2) adrenergic sedative dexmedetomidine, and cannabinoid agonists.
Inhalation anesthetics activate and cannabinoid agonists inhibit TWIK-related acid-sensitive K(+) channels (TASK)-1 two-pore… (More)
Is this relevant?
2005
2005
Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury.
CB1 cannabinoid receptors (CB1Rs) are involved in protecting the brain from ischemia and related disorders. However, the… (More)
Is this relevant?
2005
2005
Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta.
The vascular effects of cannabinoids have been compared in the rat isolated aorta. Delta9-Tetrahydrocannabinol (THC), anandamide… (More)
Is this relevant?
2004
2004
Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation.
Alcoholism is characterized by successive relapses. Recent data have shown a cross-talk between the cannabinoid system and… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism.
Glucocorticoid negative feedback in the brain controls stress, feeding, and neural-immune interactions by regulating the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
We have investigated the effects of cannabinoid agonists and antagonists on tumour necrosis factor-alpha (TNF-alpha)-induced… (More)
Is this relevant?
2002
2002
Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse.
The substantia nigra pars reticulata (SNR) belongs to the brain regions with the highest density of CB(1) cannabinoid receptors… (More)
  • figure 2
  • figure 4
  • figure 3
  • figure 5
  • figure 6
Is this relevant?